Rentokil Initial (LSE:RTO) has offered its shareholders something they have lacked in recent times: evidence that its troubled North American pest control Business may be steadying. The group followed its third-quarter update with a new $200m buyback. For income investors, the question is whether the recovery can revive a Dividend that has barely been growing, and what the company's choices say about its priorities.

A middling Yield and almost no growth

As of 7 October 2026, Rentokil's annual dividend stands at 9.2p per share, with the latest payment at 3.3p. The trailing 12-month and indicated yields are both 3.1%, which places the shares in the middle ground of the FTSE 100 for income.

Year-on-year growth of just 0.8% is the less encouraging part of the picture. Rentokil has increased its dividend for six consecutive years and has paid one for 14 years, but an increase of under 1% is close to a standstill. The growth streak is intact only narrowly, and it is the kind of figure that suggests the board has been conserving flexibility while the American integration has been worked through.

A growth streak is counted in years, not in the size of the rise, so even a token increase keeps the sequence alive. It is also why an increase of 0.8% sits oddly beside a streak of six years, and why readers should look at the rate of growth as well as the length of the streak when judging how much weight a dividend record deserves.

Cover is adequate, with limited headroom

The trailing Payout Ratio of 66.4% indicates that around two-thirds of Earnings go out as dividends, implying cover of approximately 1.5 times. That is not alarming, but it leaves less headroom than many income investors prefer, particularly for a business in the midst of a turnaround. A modest rise in earnings would provide more comfort, and that makes the operating recovery directly relevant to the outlook for the payout.

The 14-year record of payment is solid without being remarkable. It is short compared with some long-standing FTSE 100 income names, but it covers a period of considerable change, including the large Terminix Acquisition that has dominated the group's recent narrative.

Acquisitions of that size matter for dividends because they add debt, integration costs and sometimes a drag on earnings in the early years. Until those pressures ease, which can take several years, boards often prefer to keep the payout rising slowly, which fits the pattern Rentokil has shown.

Signs of stabilisation and a new buyback

Organic growth strips out the effect of acquisitions, disposals and currency, so it is the cleanest guide to how the existing business is performing. Rentokil's third-quarter trading update on 22 October reported Revenue of $1.9bn and group organic growth of 3.4%. Pest control services in North America grew 2.7% organically, with contract revenue up 3.1%, and management said it expected full-year profits to be in line with market expectations. Management did step back from its previous 20% Margin target for 2027 and did not provide detailed guidance for that year, which is a reminder that the recovery remains a work in progress.

Five days later the company announced a share buyback of up to $200m, running to no later than 24 February 2027 and executed through a broker. The stated aim is to reduce the Share Capital and cover obligations under employee share schemes. Repurchased shares will be cancelled or held in treasury for those schemes.

The decision to return additional capital through a buyback tells investors something about the board's priorities. Buybacks are flexible and can be increased or stopped as circumstances change, while dividend growth tends to be treated as a longer-term commitment. Choosing the former after such a thin dividend increase suggests caution about embedding a higher payout until the improvement is established, although a falling share count would make future per-share increases somewhat easier to fund.

The role of contract revenue

The contract revenue figure deserves particular attention. Pest control is largely a recurring business, in which customers sign agreements for regular visits. Growth in contract revenue therefore points to customers being retained and priced consistently, which feeds into Cash Flow that is more predictable than one-off treatments. Recurring income of this kind is the base on which a dividend is best built, since it changes slowly and is easier to forecast. For Rentokil (LSE:RTO), a return to steady contract growth in North America would do more for the dividend than any single quarter of total revenue.

The 2027 margin target being set aside shows how hard it is to forecast that pace, and it is a reminder that integration programmes rarely run to a neat schedule. It also explains why the market looks so closely at the North American division even though it is only one part of a global group. Its margins, pricing and customer retention set the tone for how quickly the integration benefits can feed through to earnings per share.

What to watch

Taken together, the signals are encouraging but incomplete, and the next set of results should show whether they are lasting. The full-year results early next year are the next major test, both for the 2026 profit outcome and for whatever Rentokil chooses to say about 2027 margins now that the 20% target has been set aside. The North American contract growth rate will be the most closely followed operating figure.

Income investors should look for evidence that the final dividend moves up by more than the 0.8% recorded in the latest figures, because a sustained recovery in earnings should eventually show through in the payment itself. They should also follow how much of the $200m buyback has been completed by LSE:RTO as it nears the end of its February 2027 window, since the pace will indicate how confident the board feels about cash generation.